Litcius/Paper detail

Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2

Emi Takashita, Noriko Kinoshita, Seiya Yamayoshi, Yuko Sakai-Tagawa, Seiichiro Fujisaki, Mutsumi Ito, Kiyoko Iwatsuki-Horimoto, Peter Halfmann, Shinji Watanabe, Kenji Maeda, Masaki Imai, Hiroaki Mitsuya, Norio Ohmagari, Makoto Takeda, Hideki Hasegawa, Yoshihiro Kawaoka

2022New England Journal of Medicine292 citationsDOIOpen Access PDF

Topics & Concepts

ChemistryMedicineDrugPharmacologyPotencyComponent (thermodynamics)VirologyVirusStereochemistryComputer scienceSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing
Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 | Litcius